Start for free
Start for free
CF

Cantor Fitzgerald Canada Corporation

North America, Ontario, Canada, Toronto

Description

Cantor Fitzgerald Canada Corporation is a Financial consultant

Investor Profile

Cantor Fitzgerald Canada Corporation has made 1 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cantor Fitzgerald Canada Corporation frequently co-invest with?

Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
SC
SilverArc Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
SymBiosis
SymBiosis
North America, Arkansas, United States, Bentonville
Co-Investments: 1
The Foundation for Prader-Willi Research
The Foundation for Prader-Willi Research
North America, California, United States, Walnut
Co-Investments: 1
Laurion Capital Management
Laurion Capital Management
North America, New York, United States, New York
Co-Investments: 1
The Prader-Willi Syndrome Association – USA
The Prader-Willi Syndrome Association – USA
North America, Florida, United States, Brandon
Co-Investments: 1
LG Technology Ventures
LG Technology Ventures
North America, California, United States, Santa Clara
Co-Investments: 1
Tetragon Financial Group Limited
Tetragon Financial Group Limited
North America, New York, United States, New York
Co-Investments: 1
Decheng Capital
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Cantor Fitzgerald Canada Corporation?

Aardvark Therapeutics

San Diego, California, United States

Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series CMay 9, 2024
Amount Raised: $85,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator